Press releases

In der Tübinger Neurologischen Universitätsklinik und dem Hertie-Institut für klinische Hirnforschung startet eine klinische Studie, die ein neues…

Prof. Thomas Gasser, chairman of the board of directors and director of the Department for Neurodegenerative Diseases at the HIH, has been awarded the…

Tübingen researchers led by Professor Dr. Markus Siegel can read out the content and form of a speech sound from brain signals several seconds before…

Dr. Simone Mayer and parents' initiative receive the award endowed with 50,000 euro

Tübingen researchers describe connection between action and feeling of authorship - finding sheds light on delusions of external control in…

Tübingen researchers develop a three-dimensional brain tissue model to study environmental influences on embyronal brain development in the Petri dish

For the first time in Europe, Tübingen physicians make use of an RNA therapy specifically tailored to one patient

A pioneering collaborative project between a Baden-Württemberg research team and patient association receive two million U.S. dollars

Protein plaques in the brain are the cause of Alzheimer's disease and the starting point for possible therapies. At later stages, however, the disease…

Researchers from Tübingen discover link between the protein medin and Alzheimer's disease